Gadolinium retention in the body: what we know and what we can do

Gadolinium-based contrast agents (GBCA), widely used in Magnetic Resonance Imaging (MRI) for almost 30 years, were recently shown to be deposited in the brain and to induce persistent T1 shortening in deep gray matter structures in subjects with normal renal function. The aim of the present study is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Radiologia medica Jg. 122; H. 8; S. 589 - 600
Hauptverfasser:	Tedeschi, Enrico, Caranci, Ferdinando, Giordano, Flavio, Angelini, Valentina, Cocozza, Sirio, Brunetti, Arturo
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Milan Springer Milan 01.08.2017 Springer Nature B.V
Schlagworte:	Animals Brain Brain - drug effects Brain - metabolism Contrast agents Contrast Media Contrast Media - adverse effects Contrast Media - metabolism Diagnostic Radiology Gadolinium Gadolinium - adverse effects Gadolinium - metabolism Humans Image Enhancement Imaging Interventional Radiology Magnetic Resonance Imaging Medicine Medicine & Public Health Neuroradiology NMR Nuclear magnetic resonance Organs Radiology Renal function Retention Ultrasound Gadolinium retention Gadolinium-based contrast media MRI Toxicity Dentate nucleus
ISSN:	0033-8362, 1826-6983, 1826-6983
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!